ClinicalTrials.Veeva

Menu

Changes in Intra-articular Parameters by Doppler Ultrasound in Patients With Hemophilic Ankle Arthropathy

I

Investigación en Hemofilia y Fisioterapia

Status

Completed

Conditions

Hemophilia

Treatments

Other: Manual therapy
Other: Placebo manual therapy

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT06281340
He-ankle US

Details and patient eligibility

About

Introduction: Hemophilic ankle arthropathy is manifested by functional degenerative alterations, intra-articular alterations, and chronic pain. Manual therapy techniques are used in the treatment of hemophilic ankle arthropathy for the improvement of pain and mobility.

Design. Double-blind randomized pilot trial. Aimed: To evaluate the ultrasound changes by means of Doppler imaging after manual therapy intervention.

Patients: A total of 20 adult patients with hemophilic ankle arthropathy will be recruited.

Intervention: Each manual therapy session will last approximately 50 minutes, with 1 session per week for a period of 3 weeks. The treatment program includes 10 techniques that will be administered bilaterally.

Measuring instruments: Patients will be evaluated qualitatively with ultrasound (HEAD-US scale) and assessment with Doppler ultrasound. The clinical variables will be joint damage (Hemophilia Joint Health Score) and pain intensity (Visual Analogue Scale).

Expected results: Check the safety of manual therapy in patients with hemophilia regarding subclinical bleeding. Assess changes related to joint inflammatory state with imaging techniques. Observe changes in pain intensity and joint damage.

Enrollment

20 patients

Sex

Male

Ages

30 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with hemophilia A or B.
  • Persons over 18 years of age.
  • Patients with a medical diagnosis of ankle arthropathy (with clinical assessment of more than 4 points on the Hemophilia Joint Health Score.
  • Patients on prophylactic or on-demand treatment with FVIII / FIX concentrates.
  • Sign the informed consent document.

Exclusion criteria

  • Patients with inhibitors (antibodies against FVIII or FIX) without treatment with monoclonal antibodies.
  • Patients with neurological or cognitive alterations that impede the comprehension of questionnaires and physical tests.
  • Patients who have developed an ankle hemarthrosis in the 3 months prior to the study.
  • Patients who at the time of the study are receiving ankle physiotherapy treatment.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups, including a placebo group

Experimental group
Experimental group
Description:
The patients included in the experimental group will receive a session of manual physiotherapy using joint gliding techniques, myofascial and manipulative techniques of the tobioperoneoastotalar and subtalar joints. The intervention will be performed on both ankles.
Treatment:
Other: Manual therapy
Control group
Placebo Comparator group
Description:
Patients included in the control group will receive a placebo manual physical therapy session, simulating joint sliding techniques, myofascial and manipulative techniques of the tobioperoneoastotalar and subtalar joints, without any stimulus other than the pressure exerted by the physical therapist with his hands when mobilizing the foot. The placebo intervention will be performed on both ankles.
Treatment:
Other: Placebo manual therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems